• Mouse Tissue Lysis Kit (K1038) Protocol

  2026-08-23

  The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tail, toe, or ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical testing.

• Tirbanibulin and HPV Oncogenic Pathways in HeLa

  2026-08-22

  A 2024 study shows that tirbanibulin suppresses proliferation in HPV-18-containing HeLa cells while reducing protein expression across Src–MEK-related, cell-cycle, invasion, and survival pathways. The findings extend tirbanibulin biology beyond tubulin and Src activity by proposing a mechanistic connection to HPV E6/E7 regulation and apoptosis-associated signaling.

• GM 6001 (Galardin): Mechanism-to-Assay Guide

  2026-08-22

  GM 6001, also called Galardin, is a potent broad-spectrum MMP inhibitor for dissecting extracellular matrix remodeling and protease-linked signaling. This guide connects its biochemical profile with orthogonal assay design, meniscal healing research, EGFR transactivation inhibition, and vascular migration studies.

• Oteseconazole: From MIC to Assay Meaning

  2026-08-21

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor with strong activity against multiple Candida species. This guide goes beyond mechanism to show how exposure, selectivity, resistance phenotype, and assay design should be interpreted together.

• ORAI2 and Early Postirradiation Salivary Fibrosis

  2026-08-20

  The reference study identifies an ORAI2/JNK/NFAT1 signaling axis that connects store-operated calcium entry with TGF-β1-driven fibrosis in irradiated salivary glands. Its combination of transcriptomics, pharmacologic SOCE inhibition, mechanistic signaling analysis, and salivary-function assessment provides a framework for studying early postirradiation tissue remodeling.

• Vardenafil HCl Trihydrate: Proteoform-Aware Assays

  2026-08-20

  Vardenafil HCl Trihydrate supports a layered strategy for PDE5 inhibition assay development, from molecular potency to smooth muscle function. This article shows how native-membrane proteoform analysis can improve interpretation of selectivity, cGMP signaling, and PDE6-related off-target findings.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-19

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil from single- and double-stranded DNA and can be incorporated into PCR carryover-contamination control workflows. It is intended for research DNA applications only; it is inactive toward RNA and oligonucleotides shorter than six bases and is not intended for diagnostic or medical use.

• Resiniferatoxin and TRPV1-Positive Afferents

  2026-08-19

  Szallasi’s 2023 review explains how Resiniferatoxin (RTX) converts selective TRPV1 activation into prolonged sensory silencing through desensitization, chemical inactivation, and, under targeted conditions, sensory-neuron ablation. The paper connects molecular pharmacology with preclinical, veterinary, and clinical evidence relevant to osteoarthritis, neuropathic, cancer, postoperative, and bladder pain research.

• Sodium Orthovanadate for Phosphorylation Workflows

  2026-08-18

  Sodium Orthovanadate (Na3VO4) helps preserve labile phosphotyrosine signals during adipocyte lysis, kinase assays, and pathway validation. This guide connects reversible phosphatase inhibition with the PI3K/AKT/GLUT4 workflow used to study insulin resistance, while emphasizing controls, compatibility, and troubleshooting.

• From TBK1 Signaling to Actionable Apoptosis Data

  2026-08-18

  A translational framework for connecting IRG1–itaconate–TBK1 biology with rigorous DNA-fragmentation measurement using Cy5 TUNEL workflows across tissues and cultured cells.

• Azilsartan Medoxomil Monopotassium: Translational Edge

  2026-08-17

  A mechanistic and translational perspective on Azilsartan medoxomil monopotassium (TAK 491), linking durable AT1 receptor antagonism with experimental design, cardiovascular research, and clinically relevant decision-making.

• Oteseconazole: From MIC to Exposure Design

  2026-08-17

  Oteseconazole (VT-1161) is more than a potent Candida CYP51 inhibitor. This guide shows how to translate its selectivity, species profile, and exposure-related properties into more informative antifungal assays and translational decisions.

• Trilaurin: Protocols for Lipid and Enzyme Workflows

  2026-08-16

  Trilaurin, also called Glycerol Tridodecanoate, is a water-insoluble long-chain triacylglycerol used as a lipid excipient, formulation component, and biocatalytic synthesis substrate. This guide addresses solvent selection, short-term stock preparation, particle-formulation workflows, and enzyme-reaction QC while defining why it should not be used as a direct aqueous reagent or stored routinely as a long-term solution.

• EPI-001 AR N-Terminal Domain Inhibitor Workflow

  2026-08-15

  EPI-001 provides a practical way to interrogate androgen receptor transcriptional control beyond the ligand-binding domain, with applications in prostate cancer and exploratory triple-negative breast cancer models. This workflow connects viability, AR expression, migration, and EMT readouts while highlighting solubility, vehicle, and assay-design controls.

• Gastrin I (Human) in Next-Gen GI Translation

  2026-08-14

  Gastrin I (human) offers a controlled way to interrogate CCK2 receptor signaling, proton pump activation, and gastric acid secretion while creating a disciplined bridge to hiPSC-derived intestinal organoids. This thought-leadership article outlines how translational researchers can connect receptor-level biology with gastrointestinal physiology studies, pharmacokinetic modeling, and gastrointestinal disorder research without overstating what current organoid evidence demonstrates.

7871 records 8/525 page Previous Next First page 上5页 678910 下5页 Last page